Overview
Formalized Training Cascades for Pharmacy Teams: Becoming an LGBTQ+ Ally to Improve HPV Immunization
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Start Activity
- Discuss the public health value of HPV vaccination to reduce the burden of HPV-related infections and cancers in high-risk patient populations
- Outline patient-, clinician-, and system-related facilitators and barriers of HPV vaccine acceptance, initiation, and completion among LGBTQ individuals
- Formulate pharmacy-led strategies to improve equitable and culturally competent HPV vaccination practices
HPV Vaccination and Cancer Prevention
LGBTQ+ Discrimination and Healthcare Disparities
Reducing Barriers to Care and HPV Vaccination
Ensuring an Affirming Environment
Clinical Scenarios: Using Affirming Language Adult-learning Principles and Facilitation Skills
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Clinical Pharmacy Specialist
Community Health Network
Indianapolis, IN
Paul L. Reiter, PhD
Professor, Health Behavior and Health Promotion
The Ohio State University
Columbus, OH
The following financial relationships have been provided:
Alex R. Mills, PharmD, BCACP, AAHIVP
No financial relationships to disclose
Paul L. Reiter, PhD
No financial relationships to disclose
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Discussion of scientific information on unapproved uses (SIUU), off-label, investigational, or experimental drug/device use: None
Pharmacists should consult with their state pharmacy on pharmacist vaccination authority included within their scope of practice.
Partial credit may not be awarded for CPE credit; participation in the complete activity is required to receive credit.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity has been approved for 1.5 contact hours.
ACPE Universal Activity Number: 0396-0000-24-025-H06-P and 0396-0000-24-025-H06-T
Activity Type: Application
Release Date: November 27, 2024
Expiration Date: November 27, 2025
CPE credit will be submitted to CPE Monitor® on the first business day of each month.
